Cargando…
Zanubrutinib Ameliorates Cardiac Fibrosis and Inflammation Induced by Chronic Sympathetic Activation
(1) Background: Heart failure (HF) is the final stage of multiple cardiac diseases, which have now become a severe public health problem worldwide. β-Adrenergic receptor (β-AR) overactivation is a major pathological factor associated with multiple cardiac diseases and mediates cardiac fibrosis and i...
Autores principales: | Li, Wenqi, Zhu, Shuwen, Liu, Jing, Liu, Zhigang, Zhou, Honggang, Zhang, Qianyi, Yang, Yue, Chen, Li, Guo, Xiaowei, Zhang, Tiantian, Meng, Lingxin, Chai, Dan, Tang, Guodong, Li, Xiaohe, Yang, Cheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10458081/ https://www.ncbi.nlm.nih.gov/pubmed/37630287 http://dx.doi.org/10.3390/molecules28166035 |
Ejemplares similares
-
Sympathetic Denervation Ameliorates Renal Fibrosis via Inhibition of Cellular Senescence
por: Li, Qian, et al.
Publicado: (2022) -
Duvelisib attenuates bleomycin‐induced pulmonary fibrosis via inhibiting the PI3K/Akt/mTOR signalling pathway
por: Li, Xiaohe, et al.
Publicado: (2023) -
Simultaneous development of zanubrutinib in the USA and China
por: Li, Guanqiao, et al.
Publicado: (2020) -
Preliminary Evaluation of Zanubrutinib-Containing Regimens in DLBCL and the Cerebrospinal Fluid Distribution of Zanubrutinib: A 13-Case Series
por: Zhang, Yan, et al.
Publicado: (2021) -
Imrecoxib attenuates bleomycin-induced pulmonary fibrosis in mice
por: Miao, Yang, et al.
Publicado: (2023)